(Total Views: 167)
Posted On: 05/02/2023 3:06:51 PM
Post# of 98
![](/m/assets/46931549/no_avatar_available_thumb.jpg)
BIOXYTRAN, INC. is a clinical stage biotechnology business that is developing oral and injectable medications to treat COVID-19 and other viral diseases. The current OTC stock price represents a potential buying opportunity with a market value of $61.7 million.
![](/m/images/thumb-up.png)
![](/m/images/thumb-down.png)